Why the study?
Does ruscogenin alleviate deep venous thrombosis and pulmonary embolism in mice with inferior vena cava stenosis?
Does ruscogenin alleviate deep venous thrombosis and pulmonary embolism in mice with inferior vena cava stenosis?
Ruscogenin demonstrates therapeutic potential for deep venous thrombosis and pulmonary embolism in a mouse model by inhibiting inflammation and the MEK/ERK/Egr-1/TF signaling pathway.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in a murine venous thromboembolism model; leaves open translation to human therapy.
IVCS model contributed to the development of DVT and PE in mice and was associated with increased inflammation. RUS showed therapeutic effects by inhibiting inflammation as well as suppressing the activation of MEK/ERK/Egr-1/TF signaling pathway.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: